---
title: "Aranidipine - Hypertensive Disorder"
sidebar: mydoc_sidebar
permalink: db09229-mesh-d006973-1.html
toc: false 
---


Path ID: `DB09229_MESH_D006973_1`
{% include image.html url="images/db09229-mesh-d006973-1.png" file="db09229-mesh-d006973-1.png" alt="db09229-mesh-d006973-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C059427">MESH:C059427 </a> | aranidipine | Drug |
| <a href="https://identifiers.org/UniProt:Q13936">UniProt:Q13936 </a> | Voltage-dependent L-type calcium channel subunit alpha-1C | Protein |
| <a href="https://identifiers.org/UniProt:Q01668">UniProt:Q01668 </a> | Voltage-dependent L-type calcium channel subunit alpha-1D | Protein |
| <a href="https://identifiers.org/UniProt:O60840">UniProt:O60840 </a> | Voltage-dependent L-type calcium channel subunit alpha-1F | Protein |
| <a href="https://identifiers.org/UniProt:Q13698">UniProt:Q13698 </a> | Voltage-dependent L-type calcium channel subunit alpha-1S | Protein |
| <a href="https://identifiers.org/GO:0006939">GO:0006939 </a> | smooth muscle contraction | BiologicalProcess |
| <a href="https://identifiers.org/GO:0042310">GO:0042310 </a> | vasoconstriction | BiologicalProcess |
| <a href="https://identifiers.org/HP:0032263">HP:0032263 </a> | Increased blood pressure | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D006973">MESH:D006973 </a> | Hypertensive disorder | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Aranidipine | DECREASES ACTIVITY OF | Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1C |
| Aranidipine | DECREASES ACTIVITY OF | Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1D |
| Aranidipine | DECREASES ACTIVITY OF | Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1F |
| Aranidipine | DECREASES ACTIVITY OF | Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1S |
| Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1C | POSITIVELY REGULATES | Smooth Muscle Contraction |
| Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1D | POSITIVELY REGULATES | Smooth Muscle Contraction |
| Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1F | POSITIVELY REGULATES | Smooth Muscle Contraction |
| Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1S | POSITIVELY REGULATES | Smooth Muscle Contraction |
| Smooth Muscle Contraction | POSITIVELY CORRELATED WITH | Vasoconstriction |
| Vasoconstriction | POSITIVELY CORRELATED WITH | Increased Blood Pressure |
| Increased Blood Pressure | MANIFESTATION OF | Hypertensive Disorder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB09229](https://go.drugbank.com/drugs/DB09229)
  - [https://en.wikipedia.org/wiki/Aranidipine](https://en.wikipedia.org/wiki/Aranidipine)
